0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Respiratory Antiviral Drugs Market Size, Pipeline Analysis, and ForecastExecutive Summary Respiratory Antiviral Drugs Market : Data Bridge Market Research analyses that the respiratory antiviral drugs market was valued at USD 54.4 billion in 2021 and is expected to reach USD 78.02 billion by 2029, registering a CAGR of 4.61% during the forecast period of 2022 to 2029. Market definition covered in the large scale Respiratory Antiviral Drugs...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Herpes Zoster Drug Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Herpes Zoster Drug Market : The global herpes zoster drug market was valued at USD 1.23 billion in 2024 and is expected to reach USD 3.31 billion by 2032 at the CAGR of 13.20% during the forecast period Analysis and interpretation of market research data is used to build this Herpes Zoster Drug Market industry report...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Liver Medicine Market Outlook with 10.9% CAGR Growth RateLiver Medicine focuses on therapeutic solutions that safeguard one of the body’s most vital organs responsible for filtration, nutrient processing, and metabolic regulation. It includes innovative drug classes and preventive strategies aimed at controlling inflammation, viral replication, fibrosis, and tumor growth. With expanding research in molecular biology and immunology, liver...0 Commentaires 0 Parts 319 Vue 0 Aperçu
-
Unlocking Value in the Hepatitis B Therapeutics Market – Forecast & Industry InsightsHepatitis B therapeutics include antiviral drugs that reduce viral replication and inflammation. They help in maintaining liver function. These treatments are widely used in clinical practice. Hepatitis B Therapeutics Market Overview The Hepatitis B Therapeutics Market is projected to reach US$ 7.26 billion by 2031, growing at a CAGR of 8.8% during the forecast period from 2025 to...0 Commentaires 0 Parts 283 Vue 0 Aperçu